Panacea Life Sciences Holdings annual shares outstanding
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Panacea Life Sciences Holdings Shares Outstanding History (PLSH)
Panacea Life Sciences Holdings reported 17.6M shares outstanding at the end of fiscal 2023.
View full Panacea Life Sciences Holdings company overviewPanacea Life Sciences Holdings annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2023 | 2023-12-31 | 17.6M | 2.7M | +17.91% |
| 2022 | 2022-12-31 | 15.0M | 891,609 | +6.34% |
| 2021 | 2021-12-31 | 14.1M | −2.8M | −16.80% |
| 2020 | 2020-12-31 | 16.9M | −26.9M | −61.40% |
| 2019 | 2019-12-31 | 43.8M | 37.6M | +602.96% |
| 2018 | 2018-12-31 | 6.2M | 1.8M | +42.19% |
| 2017 | 2017-12-31 | 4.4M | −29.7M | −87.13% |
| 2016 | 2016-12-31 | 34.1M | 33.6M | +6512.17% |
| 2015 | 2015-12-31 | 515,290 | −14.6M | −96.60% |
| 2014 | 2014-12-31 | 15.1M | — | — |
Panacea Life Sciences Holdings quarterly shares outstanding
Q4.14
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q1 2024 | 2024-03-31 | 18.3M | 2.8M | +18.10% |
| Q4 2023 | 2023-12-31 | 17.6M | 2.7M | +17.91% |
| Q3 2023 | 2023-09-30 | 17.6M | 2.7M | +17.91% |
| Q2 2023 | 2023-06-30 | 17.6M | 2.7M | +17.91% |
| Q1 2023 | 2023-03-31 | 15.5M | 742,975 | +5.03% |
| Q4 2022 | 2022-12-31 | 15.0M | 891,609 | +6.34% |
| Q3 2022 | 2022-09-30 | 15.0M | −6.4M | −30.05% |
| Q2 2022 | 2022-06-30 | 15.0M | −6.4M | −29.81% |
| Q1 2022 | 2022-03-31 | 14.8M | −85.0M | −85.20% |
| Q4 2021 | 2021-12-31 | 14.1M | −42.3M | −75.03% |
| Q3 2021 | 2021-09-30 | 21.4M | −31.8M | −59.80% |
| Q2 2021 | 2021-06-30 | 21.3M | −28.9M | −57.58% |
| Q1 2021 | 2021-03-31 | 99.7M | 54.0M | +118.06% |
| Q4 2020 | 2020-12-31 | 56.4M | 12.5M | +28.61% |
| Q3 2020 | 2020-09-30 | 53.2M | 13.2M | +32.95% |
| Q2 2020 | 2020-06-30 | 50.3M | 15.8M | +45.99% |
| Q1 2020 | 2020-03-31 | 45.7M | 12.6M | +37.96% |
| Q4 2019 | 2019-12-31 | 43.8M | 37.6M | +602.96% |
| Q3 2019 | 2019-09-30 | 40.0M | 248,700 | +0.63% |
| Q2 2019 | 2019-06-30 | 34.4M | −2.5M | −6.87% |
| Q1 2019 | 2019-03-31 | 33.1M | −3.6M | −9.90% |
| Q4 2018 | 2018-12-31 | 6.2M | −28.8M | −82.23% |
| Q3 2018 | 2018-09-30 | 39.8M | 6.2M | +18.48% |
| Q2 2018 | 2018-06-30 | 37.0M | 3.4M | +10.13% |
| Q1 2018 | 2018-03-31 | 36.8M | 3.2M | +9.59% |
| Q4 2017 | 2017-12-31 | 35.1M | 1.0M | +2.93% |
| Q3 2017 | 2017-09-30 | 33.6M | 141,844 | +0.42% |
| Q2 2017 | 2017-06-30 | 33.6M | 141,844 | +0.42% |
| Q1 2017 | 2017-03-31 | 33.6M | 28.9M | +625.09% |
| Q4 2016 | 2016-12-31 | 34.1M | 33.6M | +6512.17% |
| Q3 2016 | 2016-09-30 | 33.4M | 18.3M | +120.73% |
| Q2 2016 | 2016-06-30 | 33.4M | 18.3M | +120.73% |
| Q1 2016 | 2016-03-31 | 4.6M | −10.5M | −69.43% |
| Q4 2015 | 2015-12-31 | 515,290 | — | — |
| Q3 2015 | 2015-09-30 | 15.1M | — | — |
| Q2 2015 | 2015-06-30 | 15.1M | — | — |
| Q4 2014 | 2014-12-31 | 15.1M | — | — |
Panacea Life Sciences Holdings shares outstanding trends
Over the last five reported fiscal years, Panacea Life Sciences Holdings's shares outstanding moved from 6.2M to 17.6M, a change of 11.4M. The latest reported quarter, Q1 2024, shows 18.3M.
About the metric
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
Calculation and source
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Panacea Life Sciences Holdings filings at SEC.gov ↗